Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-20

Clinical Trial Update: Acetazolamide (AZ) for Management of Alkalosis in Bartter Syndrome

View source ↗

Summary

An update on a clinical trial evaluating acetazolamide for the management of alkalosis in Bartter syndrome; current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Bartter Syndrome | Status: UNKNOWN